Diagnostics AI
ByIs Butterfly Network Using AI and Handheld Imaging to Democratize Diagnostics and Transform Patient Care?
Executive Summary Butterfly Network is pioneering AI-enabled, handheld ultrasound devices designed to make imaging more accessible, affordable, and…
Is Qure.ai Powering Real-World AI Applications Across Emergency, Screening, and Population-Scale Medical Imaging?
Executive Summary Qure.ai, a global leader in AI-powered medical imaging solutions, is advancing the adoption of clinical AI…
Can AI-Automated Hematology Redefine Laboratory Diagnostics? WORK Medical Secures Manufacturing Approval for Class II Blood Cell Analyzer
Hangzhou, China – December 2025 — WORK Medical Technology Group LTD (Nasdaq: WOK) today announced that its subsidiary,…
FDA Qualifies First AI Drug Development Tool, Will Be Used in ‘MASH’ Clinical Trials to Accelerate Liver Disease Drug Development
The U.S. Food and Drug Administration (FDA) has qualified AIM-NASH, the first AI-based tool designed to assist doctors…
China’s $2-3B AI Healthcare Pilots Launch: Rural Revolution or Data Control Play?
China’s National Health Commission launched pilots March 1-3, 2026, under its CNY 15-20B ($2-3B) AI strategy—rolling out AI…
Is “ChatGPT for Doctors” Driving OpenEvidence’s $12 B Valuation Surge?
January 26, 2026 | AI in Healthcare | Strategic Investment & Market Expansion OpenEvidence, the AI platform often…
